Search

Wichtiger Faktor in der epigenetischen Kontrolle des angeborenen Immunsystems identifiziert ... Machat, Gregor Eisenwort, Stephanie Schneider, Alexandra Podhornik, Michael Kothmayer, Ursula Reichart, Martin Glösmann, Ido Tamir, Michael Mildner, Raheleh Sheibani-Tezerji, Lukas Kenner, Peter Petzelbauer, Gerda Egger, Maria Sibilia, Andrea Ablasser, Christian Seiser. DOI 10.15252/embj.2021108234... https://www.meduniwien.ac.at/web/ueber-uns/news/news-im-oktober-2021/wichtiger-faktor-in-der-epigenetischen-kontrolle-des-angeborenen-immunsystems-identifiziert/medizin-wissenschaft/

Wichtiger Faktor in der epigenetischen Kontrolle des angeborenen Immunsystems identifiziert ... Machat, Gregor Eisenwort, Stephanie Schneider, Alexandra Podhornik, Michael Kothmayer, Ursula Reichart, Martin Glösmann, Ido Tamir, Michael Mildner, Raheleh Sheibani-Tezerji, Lukas Kenner, Peter Petzelbauer, Gerda Egger, Maria Sibilia, Andrea Ablasser, Christian Seiser. DOI 10.15252/embj.2021108234... https://www.meduniwien.ac.at/web/ueber-uns/news/news-im-oktober-2021/wichtiger-faktor-in-der-epigenetischen-kontrolle-des-angeborenen-immunsystems-identifiziert/

Martin Schepelmann coordinates the "eRaDicate" EU-project to research innovative ligands for nuclear receptors to eradicate cancer relapse ...), Queensland University of Technology (Australia), Selvita S.A. (Poland), the Shaare Zedek Medical Center (Israel), and the University of Toronto (Canada), as well as Wannaboo S.r.l. (Italy). The members of the MedUniVienna “eRaDicate” team are, besides the coordinator Martin Schepelmann, Lukas Kenner (Department of Pathology), Enikö Kallay and Isabella Ellinger (both from the Institute of Pathophysiology and Allergy Research). from left: Lukas Kenner, Enikö Kallay, Martin Schepelmann and Isabella Ellinger The “eRaDicate” doctoral network (DN) is an international, multi- &... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-july-2023/martin-schepelmann-coordinates-the-eradicate-eu-project-to-research-innovative-ligands-for-nuclear-receptors-to-eradicate-cancer-relapse/

Martin Schepelmann coordinates the "eRaDicate" EU-project to research innovative ligands for nuclear receptors to eradicate cancer relapse ...), Queensland University of Technology (Australia), Selvita S.A. (Poland), the Shaare Zedek Medical Center (Israel), and the University of Toronto (Canada), as well as Wannaboo S.r.l. (Italy). The members of the MedUniVienna “eRaDicate” team are, besides the coordinator Martin Schepelmann, Lukas Kenner (Department of Pathology), Enikö Kallay and Isabella Ellinger (both from the Institute of Pathophysiology and Allergy Research). from left: Lukas Kenner, Enikö Kallay, Martin Schepelmann and Isabella Ellinger The “eRaDicate” doctoral network (DN) is an international, multi- &... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-july-2023/martin-schepelmann-coordinates-the-eradicate-eu-project-to-research-innovative-ligands-for-nuclear-receptors-to-eradicate-cancer-relapse/people-of-the-meduni-vienna/

Detailsite | MedUni Vienna ... Schramek, Hans-Peter Kantner, Mathias Müller, Thomas Kolbe, Thomas Rülicke, Richard Moriggl, Lukas Kenner, Dagmar Stoiber, Josef Martin Penninger, Helmut Popper, Emilio Casanova & Robert EferlNature Methods 2012, doi: 10.1038/nmeth.2130 Share WhatsappFacebookTwitterLinkedInXingMailBlueSky All... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/in-german-wie-zufaellige-mutationen-zum-boesartigen-zellwachstum-fuehren/

Important factor in the epigenetic control of the innate immune system identified ..., Martin Glösmann, Ido Tamir, Michael Mildner, Raheleh Sheibani-Tezerji, Lukas Kenner, Peter Petzelbauer, Gerda Egger, Maria Sibilia, Andrea Ablasser, Christian Seiser. DOI 10.15252/embj.2021108234. Share Whatsapp Facebook LinkedIn Xing Mail BlueSky All News... https://www.meduniwien.ac.at/web/en/ueber-uns/news/news-im-oktober-2021/wichtiger-faktor-in-der-epigenetischen-kontrolle-des-angeborenen-immunsystems-identifiziert/

Important factor in the epigenetic control of the innate immune system identified ..., Martin Glösmann, Ido Tamir, Michael Mildner, Raheleh Sheibani-Tezerji, Lukas Kenner, Peter Petzelbauer, Gerda Egger, Maria Sibilia, Andrea Ablasser, Christian Seiser. DOI 10.15252/embj.2021108234. Share Whatsapp Facebook LinkedIn Xing Mail BlueSky All News... https://www.meduniwien.ac.at/web/en/ueber-uns/news/news-im-oktober-2021/wichtiger-faktor-in-der-epigenetischen-kontrolle-des-angeborenen-immunsystems-identifiziert/medicine-science/

News ... Rahmen seiner Dissertation am IMBA durchgeführt, an der Auswertung der Tumoren war Lukas Kenner und sein Team von der MedUni Wien massgeblich beteiligt. In dem Labor am Institut für klinische Pathologie sowie am Ludwig Boltzmann Institut für Krebsforschung (LBI-CR) an der MedUni Wien wurde festgestellt, dass in Mäusen, denen das Knochengen RANKL fehlt, kein oder ein wesentlich geringeres Brustkrebswachstum zu beobachten war als in den Mäusen, in denen das Gen RANKL aktiv war. Weiters konnte die Arbeitsgruppe um Lukas Kenner die Zelltypen in der Brustdrüse identifizieren, von denen das maligne Wachstum... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/wie-hormone-brustkrebs-ausloesen-koennen/

FWF funding for research into new treatment options for prostate cancer ... factor for the availability of T3 in prostate cancer cells, the focus has now shifted to the signaling pathway driven by T3. The focus here is on the thyroid hormone receptor β (TRβ) as a key signaling molecule. The research group led by Prof. Lukas Kenner and Assoc. Prof. Brigitte Hantusch found that... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-december-2023/fwf-foerderung-fuer-erforschung-neuer-therapieoptionen-bei-prostatakrebs/

FWF funding for research into new treatment options for prostate cancer ... factor for the availability of T3 in prostate cancer cells, the focus has now shifted to the signaling pathway driven by T3. The focus here is on the thyroid hormone receptor β (TRβ) as a key signaling molecule. The research group led by Prof. Lukas Kenner and Assoc. Prof. Brigitte Hantusch found that... https://www.meduniwien.ac.at/web/en/about-us/news/2023/news-in-december-2023/fwf-foerderung-fuer-erforschung-neuer-therapieoptionen-bei-prostatakrebs/medicine-science/

Persons

Webseiten-Inhalte